Targeted Pulse Quiz: July 7
Test your knowledge on the current pulse of oncology including FDA updates and breaking data with our Targeted Pulse Quiz.
Ready for the challenge? Let’s begin!
What FDA designation did TUB-040 receive for platinum-resistant ovarian cancer management?
Learn more: The Targeted Pulse Week of July 7
Now let’s take your pulse. What did you think of the quiz?
Recent Videos
Related Content
Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander
October 31st 2024Podcast
In this episode of Targeted Talks, Seth Wander, MD, PhD, discusses the clinical importance of ESR1 mutations in HR-positive metastatic breast cancer and how these mutations influence treatment approaches.
Listen
